These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25559655)

  • 1. Adverse drug reaction: a possible case of glimepiride-induced syndrome of inappropriate antidiuretic hormone secretion.
    Adachi H; Yanai H
    Diabetes Metab; 2015 Apr; 41(2):176-7. PubMed ID: 25559655
    [No Abstract]   [Full Text] [Related]  

  • 2. Glimepiride for NIDDM.
    Med Lett Drugs Ther; 1996 May; 38(975):47-8. PubMed ID: 8632731
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W
    Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone + glimepiride: a combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):145. PubMed ID: 17724836
    [No Abstract]   [Full Text] [Related]  

  • 6. Pioglitazone/glimepiride (Duetact) for diabetes.
    Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
    [No Abstract]   [Full Text] [Related]  

  • 8. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Diabetes Care; 2010 Jun; 33(6):1224-9. PubMed ID: 20215447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glimepiride--an oral antidiabetic agent].
    Becić F; Kapić E; Becić E
    Med Arh; 2003; 57(2):125-7. PubMed ID: 12822388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incidence of severe secondary effects during treatment with sulfonylureas and biguanides].
    Berger W
    Journ Annu Diabetol Hotel Dieu; 1986; ():243-53. PubMed ID: 3613372
    [No Abstract]   [Full Text] [Related]  

  • 12. Lichenoid drug eruption as a result of the recently released sulfonylurea glimepiride.
    Noakes R
    Australas J Dermatol; 2003 Nov; 44(4):302-3. PubMed ID: 14616504
    [No Abstract]   [Full Text] [Related]  

  • 13. Glimepiride-induced vasculitis: a case report.
    Ben Salem C; Hmouda H; Bouraoui K
    Br J Clin Pharmacol; 2007 Jul; 64(1):113-4. PubMed ID: 17324240
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glimepiride-induced acute hepatitis].
    Dusoleil A; Condat B; Sobesky R; Pelletier G; Buffet C
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1096-7. PubMed ID: 10592884
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease.
    Fasching P
    Diabetologia; 1998 Jun; 41(6):743-4. PubMed ID: 9662063
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulphonylureas in the treatment of non-insulin-dependent diabetes.
    Ferner RE; Alberti KG
    Q J Med; 1989 Nov; 73(271):987-95. PubMed ID: 2695959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypoglycemic sulfamides: new pharmacologic data and practical implications].
    Blickle JF; Brogard JM
    Diabetes Metab; 1998 Jun; 24(3):276-80. PubMed ID: 9690064
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of the safety and tolerance of glimepiride.
    Schneider J
    Horm Metab Res; 1996 Sep; 28(9):413-8. PubMed ID: 8911975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorpropamide induced syndrome of inappropriate secretion of antidiuretic hormone.
    Ravat HK; Joshi VR
    J Assoc Physicians India; 1991 Aug; 39(8):645-6. PubMed ID: 1814884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestatic liver injury after glimepiride therapy.
    Chounta A; Zouridakis S; Ellinas C; Tsiodras S; Zoumpouli C; Kopanakis S; Giamarellou H
    J Hepatol; 2005 Jun; 42(6):944-6. PubMed ID: 15885370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.